Early diagnosis in Alzheimer’s disease: A first step towards better care
Clarivate
SEPTEMBER 11, 2024
Personalized care relies on pharmacological and non-pharmacological interventions aimed at (temporarily) relieving cognitive and non-cognitive symptoms (Alzheimer’s Association, n.d.; FDA cleared the first CSF diagnostic test based on the detection of Aβ40/Aβ42 (U.S. FDA-Approved Treatments for Alzheimer’s. Emblad, S.
Let's personalize your content